Skip to Main Navigation Skip to the Content Skip to the Footer
Clinical Trials Alliance A221805

Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study

A Clinical Trial for Colorectal cancer in
  • Baton Rouge
  • Covington
  • Houma
.

This phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer.

Learn More